# Amplify Weight Loss Drug & Treatment ETF (THNR)

> Source: Nexqual · https://nexqual.com/THNR · data as of 2026-10-23 13:46 UTC · cite as "Nexqual, Amplify Weight Loss Drug & Treatment ETF (THNR), nexqual.com/THNR" · informational, not investment advice.

**Price:** USD 24.95 (+0.00% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 24.95 · day 24.95–24.97 · 52w 22.89–27.94 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +9.8% vs S&P 500 +14.4%; 5Y +1.1% vs S&P 500 +77.0%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2024-05-20) |
|---|---|---|
| Total return | +9.8% | +1.1% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +9.9% | +0.5% |
| Volatility (annualized) | 19.1% | 20.0% |
| Max drawdown | -13.9% (Aug 2026→Oct 2026) | -30.0% (Aug 2024→Mar 2025) |

## Peers
OZEM (Roundhill GLP-1 & Weight Loss E) USD 29.64 -1.14% · HRTS (Tema Heart & Health ETF) USD 37.54 -0.64% · COWS (Amplify Cash Flow Dividend Lead) USD 39.85 -0.19% · NDIV (Amplify Energy & Natural Resour) USD 35.26 +2.02% · AIVC (Amplify Bloomberg AI Equal Weig) USD 103.49 +0.60%

## More
Full page: https://nexqual.com/THNR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt